Market Research Future

Worldwide Lung Cancer Market to Witness a Pronounce Growth at a CAGR of 13.5% by 2023

The Analysis presents the study of Global Lung Cancer Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold.


Pune, India -- (SBWIRE) -- 03/22/2018 -- published a Half-Cooked research report on "Global Lung Cancer Market Research Report - Forecast to 2023" reports to its database. – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.


The global market of Lung Cancer is expected to reach USD 36929.8 million in 2023 from USD 15219.7 million in 2016 with a CAGR of 13.5% during the forecast period 2017-2023.

The report titled "Lung Cancer Market -Forecast to 2023? is a direct appreciation by Market Research Future of the market potential of the Lung Cancer Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today's winner takes all market!

Market Synopsis of Global Lung Cancer Market:

Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung cancer (SCLC) and non-small-cell lung cancer (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers are different and the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage IV.

Key Players for Global Lung Cancer Market:

Some of the key players in this market are: F. Hoffmann-La Roche AG, Novartis, PFIZER INC, Merck & Co., Inc., BRISTOL-MYERS SQUIBB, ELI Lilly and Company, Sanofi and others.

Intended Audience:

Lung Cancer Drug Manufacturers
Cancer research facilities
Market Research and Consulting Service Providers
Hospitals & Research Laboratories

Global Lung Cancer Market has been segmented on the basis of types which comprises of SCLC and NSCLC. On the basis of treatments it is segmented into Surgery, Chemotherapy, Radiotherapy, Photodynamic therapy (PDT) and Laser therapy. On the basis of end users, it includes Hospitals & Clinics, Cancer Research Centers and Laboratories.


Regional Analysis of Global Lung Cancer Market:

The global market for Lung Cancer is growing steadily. The global lung cancer market on the basis of region comprises of North America, Europe, Asia Pacific and Middle East & Africa. The global market for Lung Cancer is growing with the CAGR of 13.5% during the forecast period from 2017-2023. NSCLC is the most common type of lung cancer globally. The global Lung Cancer market reached USD 36929.8 million in 2023 from 15219.7 million in 2016. Europe region captured the second largest market globally and is expected to reach USD 8,536.3 million by 2023 due to the growing demand and need for lung cancer drugs, and the growing prevalence of lung cancer.

The report for Global Lung Cancer Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.


2.1 Research Objective

2.2 Assumptions & Limitations

2.2.1 Assumptions

2.2.2 Limitations

2.3 Market Structure

3.1 Primary Research

3.2 Secondary Research

4.1 Introduction

4.2 Bargaining Power Of Buyer

4.3 Bargaining Power Of Suppliers

4.3.1 Threat From Substitute

4.3.2 Threat From A New Entrant

4.3.3 Intensity Of Competitive Rivalry

5.1 Drivers

5.1.1 Smoking

5.1.2 Environmental Pollution

5.1.3 Rising Cases Of Infections

5.1.4 Growing Rates Of Early Detection And Awareness

5.1.5 Rising Rates Of Fast Growing Lung Cancer

5.1.6 Reimbursements And Growing Health Insurance

5.2 Restraints

5.2.1 Poor Efficacy, Cure Rates And Side Effects Of Present Treatment

5.2.2 High Failure Rates Of Lung Transplant Surgeries

5.2.3 High Malignant Nature And Faster Growth Of Lung Cancer

5.2.4 Poor Life Expectancy And Quality Of Life Of Patients Undergoing Lung Cancer Treatment

5.2.5 Loss Of Patents Of Lung Cancer Drugs

5.2.6 Scarcity Of Lung Organ And Long Waiting Lines

5.3 Opportunities

5.3.1 Rising Research And Development

5.3.2 Huge Market

5.3.3 Rising Support From Public And Philanthropic Bodies And Increasing Collaboration Will Help To Drive Down Development Cost

5.3.4 Targeted And Genetic Therapies

5.4 Challenges

5.4.1 High Bar For Any New Treatment

5.4.2 The Scarcity Of Lung Transplant Organs



About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312